[English] 日本語
Yorodumi- EMDB-47404: Structure of RyR1 in the primed state in the presence of oxypurin... -
+
Open data
-
Basic information
| Entry | ![]() | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Title | Structure of RyR1 in the primed state in the presence of oxypurinol, focused refinement | |||||||||
Map data | Structure of RyR1 in the primed state in the presence of oxypurinol - focused refinement | |||||||||
Sample |
| |||||||||
Keywords | calcium channel / MEMBRANE PROTEIN / sarcoplasmic reticulum | |||||||||
| Biological species | ![]() | |||||||||
| Method | single particle reconstruction / cryo EM / Resolution: 2.69 Å | |||||||||
Authors | Miotto MC / Marks AR | |||||||||
| Funding support | 1 items
| |||||||||
Citation | Journal: Proc Natl Acad Sci U S A / Year: 2025Title: Targeting ryanodine receptors with allopurinol and xanthine derivatives for the treatment of cardiac and musculoskeletal weakness disorders. Authors: Marco C Miotto / Estefania Luna-Figueroa / Carl Tchagou / Laith Bahlouli / Steven Reiken / Haikel Dridi / Yang Liu / Gunnar Weninger / Andrew R Marks / ![]() Abstract: Ryanodine receptors (RyRs) are intracellular Ca channels essential for muscle contraction. Caffeine, a xanthine derivative, has been known for decades to increase muscle contraction and enhance ...Ryanodine receptors (RyRs) are intracellular Ca channels essential for muscle contraction. Caffeine, a xanthine derivative, has been known for decades to increase muscle contraction and enhance activation of RyRs by increasing the sensitivity to Ca. We previously showed that xanthine, the only physiologically relevant xanthine derivative, also binds to and activates RyR2. Most xanthine derivatives and analogs are safe and widely prescribed, with the most popular being the xanthine oxidoreductase inhibitor allopurinol (~15M yearly prescriptions in USA). We propose that xanthine derivatives and analogs that enhance RyRs activity could be used for lead optimization and eventually for the treatment of the diseases that exhibit decreased muscle contraction and reduced RyRs activity, such as RyR1-related diseases, sarcopenia, and heart failure. Here, we show by cryo-EM that xanthine derivatives, analogs, and other related compounds bind to the xanthine/caffeine binding site and activate RyR1, and identify 4-oxopyrimidine as the minimal motif necessary for such interaction. | |||||||||
| History |
|
-
Structure visualization
| Supplemental images |
|---|
-
Downloads & links
-EMDB archive
| Map data | emd_47404.map.gz | 257.1 MB | EMDB map data format | |
|---|---|---|---|---|
| Header (meta data) | emd-47404-v30.xml emd-47404.xml | 17.2 KB 17.2 KB | Display Display | EMDB header |
| Images | emd_47404.png | 35.6 KB | ||
| Filedesc metadata | emd-47404.cif.gz | 4.6 KB | ||
| Others | emd_47404_half_map_1.map.gz emd_47404_half_map_2.map.gz | 475.5 MB 475.5 MB | ||
| Archive directory | http://ftp.pdbj.org/pub/emdb/structures/EMD-47404 ftp://ftp.pdbj.org/pub/emdb/structures/EMD-47404 | HTTPS FTP |
-Validation report
| Summary document | emd_47404_validation.pdf.gz | 1.3 MB | Display | EMDB validaton report |
|---|---|---|---|---|
| Full document | emd_47404_full_validation.pdf.gz | 1.3 MB | Display | |
| Data in XML | emd_47404_validation.xml.gz | 18.8 KB | Display | |
| Data in CIF | emd_47404_validation.cif.gz | 22.5 KB | Display | |
| Arichive directory | https://ftp.pdbj.org/pub/emdb/validation_reports/EMD-47404 ftp://ftp.pdbj.org/pub/emdb/validation_reports/EMD-47404 | HTTPS FTP |
-Related structure data
| Related structure data | ![]() 9e17C ![]() 9e18C ![]() 9e19C ![]() 9e1aC ![]() 9e1bC ![]() 9e1cC ![]() 9e1dC ![]() 9e1eC ![]() 9e1fC ![]() 9e1gC ![]() 9e1hC ![]() 9e1iC C: citing same article ( |
|---|
-
Links
| EMDB pages | EMDB (EBI/PDBe) / EMDataResource |
|---|
-
Map
| File | Download / File: emd_47404.map.gz / Format: CCP4 / Size: 512 MB / Type: IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) | ||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annotation | Structure of RyR1 in the primed state in the presence of oxypurinol - focused refinement | ||||||||||||||||||||||||||||||||||||
| Projections & slices | Image control
Images are generated by Spider. | ||||||||||||||||||||||||||||||||||||
| Voxel size | X=Y=Z: 0.8365 Å | ||||||||||||||||||||||||||||||||||||
| Density |
| ||||||||||||||||||||||||||||||||||||
| Symmetry | Space group: 1 | ||||||||||||||||||||||||||||||||||||
| Details | EMDB XML:
|
-Supplemental data
-Half map: #1
| File | emd_47404_half_map_1.map | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Projections & Slices |
| ||||||||||||
| Density Histograms |
-Half map: #2
| File | emd_47404_half_map_2.map | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Projections & Slices |
| ||||||||||||
| Density Histograms |
-
Sample components
-Entire : Complex of RyR1 and Calstabin-1
| Entire | Name: Complex of RyR1 and Calstabin-1 |
|---|---|
| Components |
|
-Supramolecule #1: Complex of RyR1 and Calstabin-1
| Supramolecule | Name: Complex of RyR1 and Calstabin-1 / type: complex / ID: 1 / Parent: 0 |
|---|
-Supramolecule #2: Ryanodine Receptor 1
| Supramolecule | Name: Ryanodine Receptor 1 / type: complex / ID: 2 / Parent: 1 |
|---|---|
| Source (natural) | Organism: ![]() |
-Supramolecule #3: Calstabin-1
| Supramolecule | Name: Calstabin-1 / type: complex / ID: 3 / Parent: 1 / Details: Peptidyl- cis-trans isomerase FKBP1A |
|---|---|
| Source (natural) | Organism: ![]() |
-Experimental details
-Structure determination
| Method | cryo EM |
|---|---|
Processing | single particle reconstruction |
| Aggregation state | particle |
-
Sample preparation
| Concentration | 10 mg/mL | |||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buffer | pH: 7.4 Component:
Details: 2 mM oxypurinol was added to the final sample from a 100 mM stock solution in 100% DMSO. | |||||||||||||||||||||||||||
| Vitrification | Cryogen name: ETHANE / Instrument: FEI VITROBOT MARK IV |
-
Electron microscopy
| Microscope | TFS KRIOS |
|---|---|
| Temperature | Min: 80.0 K / Max: 100.0 K |
| Specialist optics | Energy filter - Name: GIF Bioquantum / Energy filter - Slit width: 20 eV |
| Image recording | Film or detector model: GATAN K3 BIOQUANTUM (6k x 4k) / Digitization - Dimensions - Width: 5760 pixel / Digitization - Dimensions - Height: 4092 pixel / Average electron dose: 58.0 e/Å2 |
| Electron beam | Acceleration voltage: 300 kV / Electron source: FIELD EMISSION GUN |
| Electron optics | C2 aperture diameter: 100.0 µm / Illumination mode: FLOOD BEAM / Imaging mode: BRIGHT FIELD / Cs: 2.7 mm / Nominal defocus max: 1.5 µm / Nominal defocus min: 0.5 µm |
| Sample stage | Specimen holder model: FEI TITAN KRIOS AUTOGRID HOLDER / Cooling holder cryogen: NITROGEN |
| Experimental equipment | ![]() Model: Titan Krios / Image courtesy: FEI Company |
+
Image processing
-Atomic model buiding 1
| Initial model | PDB ID: Chain - Source name: PDB / Chain - Initial model type: experimental model |
|---|
Movie
Controller
About Yorodumi



Keywords
Authors
Citation



































Z (Sec.)
Y (Row.)
X (Col.)




































FIELD EMISSION GUN

